Statistical tests were performed using GraphPad Instat (GraphPad Software). blockade of Clflux inhibits both volume changes and cell invasion. Hence, invading glioma cells use hydrodynamic volume changes to meet the spatial constraints imposed within the brain, using essentially all free, unbound cytoplasmic water to maximally alter their volume as they invade. == Introduction == Glial-derived tumors, also known as gliomas, have limited treatment options and carry a dismal prognosis with median patient Satraplatin survival time of 12 months from diagnosis (Krex et al., 2007). Notoriously, gliomas invade into surrounding brain tissue, limiting successful surgical resection and increasing recurrence (Giese et al., 1994). The capacity of gliomas to infiltrate the brain has been extensively studied, emphasizing intercellular interactions and the invading cell’s ability to degrade the extracellular matrix (Berens et al., 1994;Giese et al., 1994;Tysnes et al., 1996;Ohnishi et al., 1997;Belin et al., 1999;Demuth and Berens, 2004). Rather than spreading hematogenously, as is common among tumors, glioma cells migrate along white matter tracks or use the vasculature’s abluminal surface as a conduit (Rutka et al., 1988;Pedersen et al., 1995). It is unclear how the physical constraints of extracellular spaces affect invading cells. Electron micrographic images portray invading glioma cells as elongated, slender wedge-shaped (Soroceanu et al., 1999), consistent with cell volume reduction. Volume changes may MGC102762 permit cells to adapt to environmental spatial constraints, yet alternatively cells may undergo shape changes while maintaining a constant volume. Therefore, one principal objective of Satraplatin this study was to determine whether cell invasion is intrinsically associated with and may even require changes in overall cell volume. Previous studies suggest that cell volume changes that occur as a result of osmotic changes use K+and Clions. Satraplatin These ions flux via channels and transporters along with obligated water to reestablish the normal cellular volume (Sontheimer, 2008). Putative K+and Clchannels that engage in volume changes of glioma cells have been identified through molecular cloning and biophysical studies. These channels include gBK, a Ca2+-activated K+channel, and ClC-2 and ClC-3, voltage-gated Clchannels (Liu et al., 2002;Olsen et al., 2003). However, it unknown whether spontaneously occurring volume changes of invading cells are similarly accompanied by ion flux, yet indirect evidence using pharmacological inhibition or experimental downregulation of channel expression with shRNA suggests this to be the case (Soroceanu et al., 1999;Ransom et al., 2001;McFerrin and Sontheimer, 2006;Weaver et al., 2006;Habela et al., 2009;Cuddapah and Sontheimer, 2010;Lui et al., 2010). Hence in this study, we set out to examine whether glioma cells modulate their cell volume during invasion through extracellular spaces in the living brain, in brain tissue, or in artificial barrier membranes. We asked whether cell volume changes are necessary for cell invasion and, if so, whether these are mediated by the coordinated flux of ions acting as osmolytes. Using quantitative three-dimensional multiphoton and confocal time-lapse microscopy, we imaged cell invasionin vivo,in situ, andin vitro. We show that in each condition, invading glioma cells decreased their volume by 3035%, regardless of their starting volume or the size of Satraplatin the barrier encountered. These values resembled the maximally achievable cellular volume decrease as determined through hyperosmotic dehydration experiments, suggesting that invading cells secrete essentially all the osmotically active cytoplasm to maximize their chance of crossing narrow barriers. == Materials and Methods == == == == == == Cell culture. == D54-MG and U251-MG glioma cells (WHO IV, glioblastoma multiforme) were gifts from Dr. D. Bigner (Duke University, Durham, NC), and Dr. Yancey Gillespie (University of Alabama at Birmingham, Birmingham, AL), respectively. Stable EGFP-expressing daughter lines (D54-EGFP and U251-EGFP) were developed through transfection with pEGFP-N1 (Clontech). Cells were grown in DMEM/F-12 supplemented with 2 mml-glutamine (Invitrogen) with 7% fetal bovine serum (FBS; Aleken Biologicals) at 37C and 10% CO2. Plasmid insertion was maintained with G418 disulfate salt (Invitrogen). == Solutions. == Unless otherwise stated, all reagents used were purchased from Sigma Aldrich. Drugs were directly added to 17% serum in media or migration assay buffer (MAB; 0.1% fatty acid free-BSA in serum-free media supplemented with 2 mml-glutamine) from stock solutions. 5-Nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) andR-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid (DIOA) were suspended at 1000 final concentration in DMSO, epidermal growth factor (EGF) was dissolved at 1000 final concentration in 0.2% BSA in water, and.